Exact Mass: 323.1533

Exact Mass Matches: 323.1533

Found 150 metabolites which its exact mass value is equals to given mass value 323.1533, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Galipine

3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline

C20H21NO3 (323.1521)

L-4-Hydroxyphenylglycyl-L-arginine

L-4-Hydroxyphenylglycyl-L-arginine; L-pHPg-L-Arg

C14H21N5O4 (323.1593)

Rucaparib

C19H18FN3O (323.1434)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

Naftifine hydrochloride

C21H22ClN (323.1441)

D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

Cyproheptadine hydrochloride

C21H22ClN (323.1441)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D003879 - Dermatologic Agents > D000982 - Antipruritics D005765 - Gastrointestinal Agents D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cyproheptadine hydrochloride is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders[1][2].

Mukonicine

13,15-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11(16),12,14-heptaene

C20H21NO3 (323.1521)

Mukonicine is found in herbs and spices. Mukonicine is an alkaloid from the leaves of Murraya koenigii (curry leaf tree

Koenigicine

13,14-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)

Koenigicine is found in herbs and spices. Koenigicine is an alkaloid from the leaves of Murraya koenigii (curryleaf tree

N-Monodemethylolopatadine

2-[(2Z)-2-[3-(methylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl]acetic acid

C20H21NO3 (323.1521)

N-Monodemethylolopatadine is a metabolite of olopatadine. Olopatadine hydrochloride is an antihistamine (as well as anticholinergic) and mast cell stabilizer, sold as a prescription eye drop (0.2\\% solution, Pataday, manufactured by Alcon). It is used to treat itching associated with allergic conjunctivitis. Olopatadine hydrochloride 0.1\\% is sold as Patanol (or Opatanol in some countries). A nasal spray formulation is sold as Patanase, which was approved by the FDA on April 15, 2008. (Wikipedia)

7-[(2-Benzyl-3-sulfanylpropanoyl)amino]heptanoic acid

7-[(2-Benzyl-1-hydroxy-3-sulphanylpropylidene)amino]heptanoic acid

C17H25NO3S (323.1555)

Cyamemazine

10-[3-(dimethylamino)-2-methylpropyl]-10H-phenothiazine-2-carbonitrile

C19H21N3S (323.1456)

N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Cyamemazine is a neuroleptic agent that contains the phenothiazine chromophore. Cyamemazine is often used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki of 12 nM), 5-HT2A (Ki = 1.5 nM) and 5-HT2C (Ki of 75 nM) receptors antagonist with antipsychotic activity[1][2].

Rubraca

6-fluoro-2-{4-[(methylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13)-tetraen-9-one

C19H18FN3O (323.1434)

5HPP-33

2-(2,6-Diisopropylphenyl)-5-hydroxyisoindoline-1,3-dione

C20H21NO3 (323.1521)

CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5211 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5213 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5254; ORIGINAL_PRECURSOR_SCAN_NO 5252 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5226; ORIGINAL_PRECURSOR_SCAN_NO 5223 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5314; ORIGINAL_PRECURSOR_SCAN_NO 5312 ORIGINAL_ACQUISITION_NO 5234; CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5234; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9749; ORIGINAL_PRECURSOR_SCAN_NO 9744 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9783; ORIGINAL_PRECURSOR_SCAN_NO 9781 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9807; ORIGINAL_PRECURSOR_SCAN_NO 9805 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9830; ORIGINAL_PRECURSOR_SCAN_NO 9826 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9801; ORIGINAL_PRECURSOR_SCAN_NO 9798 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9831; ORIGINAL_PRECURSOR_SCAN_NO 9828

Dimefline HCL

C20H21NO3 (323.1521)

R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

Phe-Ala-Ser

C15H21N3O5 (323.1481)

2-[6-(diethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C14H21N5O4 (323.1593)

relative retention time with respect to 9-anthracene Carboxylic Acid is 0.710 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.712 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.707 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.708

Oprea1_325596

C20H21NO3 (323.1521)

orientidine

C20H21NO3 (323.1521)

C20H21NO3

C20H21NO3 (323.1521)

(+)-(S)-N-propionylcaaverine

C20H21NO3 (323.1521)

apocavidine

C20H21NO3 (323.1521)

Melosatin C

C20H21NO3 (323.1521)

3-O-methylglycocitrine-II|O3-Me-Glycocitrine II

C20H21NO3 (323.1521)

Arg-Tyr

C14H21N5O4 (323.1593)

1-Hydoxy-3-methoxy-2-(3-methyl-2-butenyl)-10-methylacridone|1-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)-N-methylacridan-9-one

C20H21NO3 (323.1521)

Salviamine E

C20H21NO3 (323.1521)

Ser Ala Phe

C15H21N3O5 (323.1481)

His Pro Ala

C14H21N5O4 (323.1593)

Phe Ser Ala

C15H21N3O5 (323.1481)

MS000237945

C15H21N3O5 (323.1481)

Pro Ala His

C14H21N5O4 (323.1593)

Phe Thr Gly

C15H21N3O5 (323.1481)

Ser Phe Ala

C15H21N3O5 (323.1481)

Ala Ser Phe

C15H21N3O5 (323.1481)

Thr Gly Phe

C15H21N3O5 (323.1481)

Gly Phe Thr

C15H21N3O5 (323.1481)

Thr Phe Gly

C15H21N3O5 (323.1481)

Ala Pro His

C14H21N5O4 (323.1593)

Ala Phe Ser

C15H21N3O5 (323.1481)

Gly Thr Phe

C15H21N3O5 (323.1481)

Phe Gly Thr

C15H21N3O5 (323.1481)

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)Propanoic acid

C14H21N5O4 (323.1593)

FT-0773914

C15H21N3O5 (323.1481)

SCHEMBL10716722

C15H21N3O5 (323.1481)

Naftifine HCl

C21H22ClN (323.1441)

Ala Ala Tyr

C15H21N3O5 (323.1481)

Ala His Pro

C14H21N5O4 (323.1593)

Phe Ala Ser

C15H21N3O5 (323.1481)

Ala Tyr Ala

C15H21N3O5 (323.1481)

His Ala Pro

C14H21N5O4 (323.1593)

Pro His Ala

C14H21N5O4 (323.1593)

Tyr Ala Ala

C15H21N3O5 (323.1481)

dolasetron

C20H21NO3 (323.1521)

3-Pyrrolidineacetic acid, 1-ethyl-5-oxo-4,4-diphenyl- (9CI)

C20H21NO3 (323.1521)

Kenidine

13,14-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)

Mukonicine

13,15-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)

2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine

C19H21N3S (323.1456)

1-CBZ-2-BENZYLPIPERIDIN-4-ONE

C20H21NO3 (323.1521)

Metiapine

C19H21N3S (323.1456)

C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

tert-butyl 4-(5-nitropyridin-2-yl)oxypiperidine-1-carboxylate

C15H21N3O5 (323.1481)

1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID

C17H22FNO4 (323.1533)

tert-butyl 4-(3-nitropyridin-2-yl)oxypiperidine-1-carboxylate

C15H21N3O5 (323.1481)

Mepixanox

C20H21NO3 (323.1521)

R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent